Andreas Ingham
University of Copenhagen
9 Papers
8 Citations
Andreas Ingham is an academic researcher from University of Copenhagen. The author has contributed to research in topics: ATRX & Pregnancy. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
SARS-CoV-2 in first trimester pregnancy: a cohort study.
N. la Cour Freiesleben,N. la Cour Freiesleben,Pia Egerup,Kathrine Vauvert Römmelmayer Hviid,E. R. Severinsen,Astrid Marie Kolte,David Westergaard,David Westergaard,David Westergaard,L. Fich Olsen,Lisbeth Prætorius,Anne Zedeler,Ann-Marie Hellerung Christiansen,Josefine Reinhardt Nielsen,Didi Bang,Sine Berntsen,J. Ollé-López,Andreas Ingham,J. Bello-Rodríguez,D. M. Storm,J. Ethelberg-Findsen,Eva Hoffmann,Charlotte Wilken-Jensen,Finn Stener Jørgensen,Finn Stener Jørgensen,Henrik Westh,Henrik Westh,Henrik L. Jørgensen,Henrik L. Jørgensen,Henriette Svarre Nielsen +29 more
TL;DR: The data indicate that infection with SARS-CoV-2 in not hospitalized women does not pose a significant threat in first trimester pregnancies and follow up studies are needed to establish any risk to a fetus exposed to maternal Sars-Cov-2 infection.
Geometry Design, Principles and Assembly of Micromotors
Huanpo Ning,Yan Zhang,Hong Zhu,Andreas Ingham,Gaoshan Huang,Yongfeng Mei,Alexander A. Solovev +6 more
TL;DR: This review summarizes recent achievements in the field of nano-/micromotors, and methods of their external control and collective behaviors, which may stimulate new ideas for a broad range of applications.
61
ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors
David Pladevall-Morera,María Castejón-Griñán,Paula Aguilera,Karina Gaardahl,Andreas Ingham,Jacqueline A. Brosnan-Cashman,Alan K. Meeker,Andrés J. López-Contreras +7 more
TL;DR: It is shown that multi-targeted receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors cause higher cellular toxicity in high-grade glioma ATRX-deficient cells, and combinatorial treatments with TMZ and RTKi may increase the therapeutic window of opportunity in patients who suffer high- grade gliomas with ATRZ mutations.
Impact of SARS-CoV-2 antibodies at delivery in women, partners and newborns
Pia Egerup,Line Fich Olsen,Ann-Marie Hellerung Christiansen,Westergaard D,E. R. Severinsen,Hviid Kvr,Astrid Marie Kolte,Boje Ad,Bertelsen Mmf,Lisbeth Prætorius,Anne Zedeler,Didi Bang,Sine Berntsen,J. Ethelberg-Findsen,D. M. Storm,J. Bello-Rodríguez,Andreas Ingham,J. Ollé-López,Eva Hoffmann,Charlotte Wilken-Jensen,Lone Krebs,Joergensen Fs,Westh Ht,Jorgensen Hl,la Cour Freiesleben N,Henriette Svarre Nielsen +25 more
TL;DR: This large prospective cohort study reports no association between COVID-19 and obstetric- or neonatal complications and the family pattern showed a substantial increase in absolute risk for women living with a partner with antibodies.
5
SARS-CoV-2 in first trimester pregnancy – does it affect the fetus?
Nina la Cour Freiesleben,Nina la Cour Freiesleben,Pia Egerup,Kathrine Vauvert Römmelmayer Hviid,E. R. Severinsen,Astrid Marie Kolte,Astrid Marie Kolte,David Westergaard,David Westergaard,Line Fich Olsen,Lisbeth Prætorius,Anne Zedeler,Ann-Marie Hellerung Christiansen,Josefine Reinhardt Nielsen,Didi Bang,Sine Berntsen,J. Ollé-López,Andreas Ingham,J. Bello-Rodríguez,D. M. Storm,J. Ethelberg-Findsen,Eva Hoffmann,Charlotte Wilken-Jensen,Finn Stener Jørgensen,Finn Stener Jørgensen,Henrik Westh,Henrik Westh,Henrik L. Jørgensen,Henrik L. Jørgensen,Henriette Svarre Nielsen,Henriette Svarre Nielsen +30 more
TL;DR: Maternal SARS-CoV-2 infection did not seem harmful in first trimester pregnancies, Infection had no effect on the nuchal translucency thickness and women with Sars-Cov-2 antibodies were not overrepresented among women with pregnancy loss.